Heart Association and AstraZeneca Strengthen Innovation in Cardiac Care

The Saudi Heart Association and AstraZeneca have signed a memorandum of understanding to enhance cooperation in the field of cardiovascular health, supporting the transformation of scientific knowledge and innovation into clinical practices that help improve patient care in the Kingdom.
The memorandum focuses on supporting research and scientific studies, expanding knowledge exchange through specialized conferences and forums, developing the capabilities of health practitioners, and improving care for patients with high blood pressure, thereby enhancing the quality and efficiency of cardiac services.
Association President Dr. Walid Al-Habib affirmed that the partnership represents an important step toward elevating cardiac care standards, empowering health cadres, and improving treatment outcomes, positively reflecting on patients' health and quality of life.